CANCER

Twin antibodies may help fight coronavirus- normal speech may spread virus

Twin antibodies may help fight coronavirus- normal speech may spread virus

Published 13/05/2020

(Reuters) - The following is a brief roundup of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for [more…]

Bayer more stringent in glyphosate settlement talks due to downturn

Bayer more stringent in glyphosate settlement talks due to downturn

Published 27/04/2020

FRANKFURT (Reuters) - German drugs and pesticides company Bayer said the economic downturn has prompted it to take a tougher stance in talks to settle [more…]

On eve of Brexit, Britain faces critical test to defend drug trial crown

On eve of Brexit, Britain faces critical test to defend drug trial crown

Published 30/01/2020

LONDON (Reuters) - It’s 2023. Britain’s brightest and best drug researchers are packing their bags as clinical trials start to dwindle, leaving a nation renowned [more…]

Merck’s Keytruda wins U.S. FDA approval for bladder cancer

Merck’s Keytruda wins U.S. FDA approval for bladder cancer

Published 08/01/2020

(Reuters) - The U.S. Food and Drug Administration said on Wednesday it approved Merck & Co Inc’s Keytruda for a hard-to-treat form of bladder cancer, [more…]

Strides in lung cancer lead steep decline in U.S. death rates

Strides in lung cancer lead steep decline in U.S. death rates

Published 08/01/2020

(Reuters Health) - Cancer death rates in the United States fell 2.2% from 2016 to 2017 - the largest single-year drop ever recorded - fueled [more…]

U.S. government says verdict in Bayer’s Roundup case should be reversed

U.S. government says verdict in Bayer’s Roundup case should be reversed

Published 21/12/2019

(Reuters) - The U.S. Environmental Protection Agency and the Justice Department said a federal appeals court should reverse a lower court verdict finding Bayer AG [more…]

U.S. FDA declines to approve GSK drugs division’s long acting HIV injection

U.S. FDA declines to approve GSK drugs division’s long acting HIV injection

Published 21/12/2019

(Reuters) - GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV [more…]

Half of lymphoma patients alive three years after Gilead cell therapy treatment: study

Half of lymphoma patients alive three years after Gilead cell therapy treatment: study

Published 07/12/2019

(Reuters) - Nearly half of lymphoma patients treated with Gilead Sciences Inc’s Yescarta were alive at least three years after a one-time infusion of the [more…]

Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal

Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal

Published 07/12/2019

(Reuters) - Bristol-Myers Squibb Co on Saturday said that an experimental cancer therapy it acquired as part of its $74 billion deal for Celgene Corp [more…]

Bristol-Myers, bluebird therapy for multiple myeloma succeeds in mid-stage trial

Bristol-Myers, bluebird therapy for multiple myeloma succeeds in mid-stage trial

Published 06/12/2019

(Reuters) - Bristol-Myers Squibb Co and bluebird bio Inc said on Friday their experimental therapy for a type of multiple myeloma met the main goal [more…]